Pomerantz Opens Neogen Investor Investigation Following FDA Warning Over Contaminated Veterinary Product
UNITED STATES — 28 October 2026: Pomerantz LLP has launched an investigation into...
NAPLES, Florida, US, and CAMBRIDGE, United Kingdom — 28 October 2026: Biopharmaceutical development company CDT Equity Inc. (NASDAQ: CDT) has entered into an evaluation...
Veterinary professionals examine how AI can support everyday practice
LONDON, 27 October 2026: Veterinary professionals are increasingly exploring how artificial intelligence can support clinical and...
Executive perspective: Pet Food is Becoming more than a Food Category
The global pet food industry is approaching a strategic inflection point. Its next phase...
Global trade in corn (maize) and soybean meal remains central to the economics of poultry, swine, dairy, beef and aquaculture production. Corn provides a...
Integrated antibody R&D targets a key bottleneck in veterinary biologics
27 October 2026 — Animal Health Biotechnology: Creative Biolabs is highlighting an integrated research and...
UNITED STATES — 26 October 2026: Companion-animal biotechnology company VETARYS has announced a research collaboration with Antigenesis Biologics to develop an investigational combination immunotherapy...
Eko Vet+ | CANINEBEAT AI combines digital auscultation and artificial intelligence to help veterinarians identify heart murmurs associated with structural heart disease and facilitate...
Redwood City-based Familiar Therapeutics has launched with US$5 million in seed funding to develop veterinary medicines from drug programmes originating in human pharmaceutical research....
WELLINGTON, New Zealand — AgriZeroNZ, the joint public-private entity driving New Zealand’s agricultural emissions-reduction pipeline, has secured an additional NZ$117 million (approx. US$65.7 million)...
